Jefferies Group’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$2.82M Buy
+86,900
New +$3.58M 0.02% 496
2022
Q1
Sell
-96,200
Closed -$7.49M 1644
2021
Q4
$7.49M Buy
96,200
+85,700
+816% +$7.56M 0.04% 345
2021
Q3
$1M Buy
+10,500
New +$1.11M 0.01% 991
2021
Q2
Sell
-88,200
Closed -$11.6M 1759
2021
Q1
$11.6M Buy
+88,200
New +$12.1M 0.1% 164
2020
Q1
Sell
-54,400
Closed -$5.03M 2213
2019
Q4
$5.03M Buy
+54,400
New +$4.78M 0.04% 512
2019
Q3
Sell
-40,000
Closed -$4.72M 2793
2019
Q2
$4.72M Buy
+40,000
New +$4.03M 0.03% 499
2019
Q1
Sell
-37,300
Closed -$2.35M 2404
2018
Q4
$2.35M Buy
37,300
+27,300
+273% +$1.87M 0.02% 739
2018
Q3
$789K Buy
+10,000
New +$652K 0.01% 1441
2016
Q2
Sell
-142,700
Closed -$962K 2215
2016
Q1
$962K Hold
142,700
0.01% 1160
2015
Q4
$1.32M Buy
+142,700
New +$1.33M 0.01% 1053

Other funds holding EXAS

Jefferies Group's EXAS Position: Q3 2022 in Review

Jefferies Group opened a new position in Exact Sciences (EXAS) in Q3 2022: 14,000 shares worth $455K. The stake represents ﹤0.01% of the portfolio and ranks #1064 among its holdings. This is a return to the name: Jefferies Group previously reported a position in EXAS as recently as Q4 2021.

Jefferies Group first reported a position in EXAS in Q4 2013 and has held it in 22 quarters since. The position peaked at $14.1M in Q1 2021. 479 funds tracked by Wall St. Rank hold EXAS as of Q3 2022.

  • Jefferies Group held 14,000 shares of Exact Sciences worth $455K as of Q3 2022.
  • Exact Sciences was a new Jefferies Group position in Q3 2022.
  • Exact Sciences made up ﹤0.01% of Jefferies Group's portfolio in Q3 2022, its #1064 holding.
  • Jefferies Group first reported a position in Exact Sciences in Q4 2013 and has held it in 22 quarters since.
  • Jefferies Group's Exact Sciences position peaked at $14.1M in Q1 2021.
  • 479 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2022.

Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.